Barbara Rizzardi
Internal Medicine · Sandy, UTNPI 1245385319
Payments from drug & device makers
Across 5,021 payments — averaging $5540.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$8.8M
- Emergent Biosolutions Inc.$3.2M
- Pfizer$3M
- AstraZeneca$2.8M
- GSK$1.5M
- Seqirus USA Inc$991K
- plus $7.5M from 41 others
Across 50 payments — averaging $5075.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$225K
- Eli Lilly$22K
- Sanofi US Services Inc.$3K
- GSK$2K
- Bavarian Nordic A/s$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$27,817,897 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.
Other internal medicine in Sandy
- Michael KillpackSandy$2M
- Ahad SabetSalt Lake City$34.5M
- Willard DereSalt Lake City$4.7M
- Joseph WoolleySaint George$3.6M
- Justin MansfieldOgden$3.1M
- Cuper Martinez SantibanezWest Valley City$1M
- Joshua OaksBountiful$973K
- Brandon WebbSalt Lake City$544K
- Yong Hui AhnSlc$474K
- Larry StakerSalt Lake City$441K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.